ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 28 filers reported holding ASLAN PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $798 | -20.2% | 2,217 | +38.6% | 0.00% | – |
| Q3 2022 | $1,000 | -83.3% | 1,600 | -74.9% | 0.00% | – |
| Q1 2022 | $6,000 | -71.4% | 6,369 | -46.0% | 0.00% | – |
| Q3 2021 | $21,000 | +50.0% | 11,793 | +176.6% | 0.00% | – |
| Q2 2021 | $14,000 | +600.0% | 4,264 | +616.6% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 595 | -52.2% | 0.00% | – |
| Q4 2020 | $2,000 | -33.3% | 1,246 | -16.8% | 0.00% | – |
| Q2 2020 | $3,000 | -25.0% | 1,498 | -62.4% | 0.00% | – |
| Q1 2020 | $4,000 | – | 3,984 | +2556.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 150 | -96.3% | 0.00% | – |
| Q3 2019 | $7,000 | -22.2% | 4,077 | +39.8% | 0.00% | – |
| Q2 2019 | $9,000 | -35.7% | 2,917 | -13.5% | 0.00% | – |
| Q1 2019 | $14,000 | 0.0% | 3,374 | -10.4% | 0.00% | – |
| Q4 2018 | $14,000 | – | 3,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 1,194,070 | $3,940,000 | 2.71% |
| Sio Capital Management, LLC | 1,488,508 | $4,912,000 | 1.22% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $8,298,000 | 0.85% |
| KNOTT DAVID M | 478,186 | $1,578,000 | 0.56% |
| Logos Global Management LP | 2,000,000 | $6,600,000 | 0.56% |
| DAFNA Capital Management LLC | 677,500 | $2,236,000 | 0.47% |
| Vivo Capital, LLC | 2,840,909 | $9,375,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 765,276 | $2,525,000 | 0.36% |
| MYDA Advisors LLC | 211,165 | $697,000 | 0.17% |
| Parkman Healthcare Partners LLC | 225,881 | $745,000 | 0.16% |